Tissuemed is pleased to confirm that two key patents relating to the company’s Tissuebond™ bioadhesive polymer and its unique TissuePatch™ surgical sealant film products have recently been published by the United States Patent and Trademark Office (USPTO) as US 8,133,504 and US 8,133,336 respectively.
Dr David Mandley, Tissuemed’s CEO commented, ‘I’m delighted that these two key patents supporting Tissuemed’s sealant film technology have been granted by the USPTO. Both approvals are an acknowledgement of the innovative approach that Tissuemed have taken in developing the TissuePatch product family’.
For further information about the TissuePatch product family of surgical sealant films and potential collaborative opportunities contact Tissuemed at info@tissuemed.com